Introduction
============

Schwann cells (SCs), an important component of the peripheral nervous system (PNS) that wrapping both myelinated and unmyelinated nerve fibers, could excrete a large number of growth factors to promote axonal growth and myelinization ([@B18]; [@B43]). Damage to SCs is likely to induce cell apoptosis and restrict functional recovery of peripheral nerves ([@B49]). It is reported in previous studies that apoptosis of SCs caused by oxidative stress is the common and vital mechanism of peripheral neuropathy ([@B32]). Oxidative stress-induced cell apoptosis is implicated as an important pathogenic factor in many neurodegenerative diseases ([@B29]; [@B2]; [@B11]; [@B7]). H~2~O~2~ known as a precursor of reactive oxygen species (ROS) ([@B38]), can cause dysfunction of DNA synthesis, protein expression, and mitochondria structure, and also complete disruption of cellular integrity and cell function ([@B31]; [@B10]; [@B39]). Accordingly, inhibition of the oxidative damage to SCs will improve the potential ability of protection from damage and regenerative efficacy of peripheral nerve injuries.

*Achyranthes bidentata*, listed in the Chinese Pharmacopoeia, is a significant medicinal plant with multiple therapeutic effects, such as anti-inflammatory, antipyretic, and diuretic activities ([@B15]). In previous research, we found that *A. bidentata* polypeptides (ABPP) that isolated from the aqueous extract of *A. bidentata* Blume possesses a protective effect on *N*-methyl-[D]{.smallcaps}-aspartate (NMDA)-induced apoptosis of hippocampal neurons ([@B35]) and could promote peripheral nerve regeneration in rats and rabbits ([@B47]; [@B40]; [@B5]). Furthermore, ABPPk purified by HPLC, exhibits excellent neuron-protective efficiency ([@B46]; [@B30]). However, little is known about the mechanism by which ABPPk exerts its protective role on SCs, especially in the aspect of oxidative stress. Consequently, the aim of this research is to validate the hypothesis whether ABPPk has a cytoprotective effect on SCs against oxidative stress damage *in vitro* and to reveal its underlying molecular mechanism.

In our study, we used H~2~O~2~-induced cell apoptosis models to investigate the potential cytoprotective activity of ABPPk on SCs. Results revealed that ABPPk treatment significantly protects SCs from apoptosis in oxidative stress induced by H~2~O~2~. Nevertheless, the beneficial effects of ABPPk against oxidative stress damage likely coupled with the PI3K/AKT and ERK1/2 signaling pathways. It is suggested that ABPPk treatment is potentially a useful intervention of preventing SCs against oxidative stress-induced cell apoptosis.

Materials and Methods {#s1}
=====================

Preparation of ABPPk
--------------------

ABPP was extracted from *A. bidentata* Blume, which was obtained from a Chinese medicine grocery, identified by Professor Haoru Zhao from China Pharmaceutical University ([@B30]). HPLC was further used to purify ABPP and the preparation protocol of ABPPk was previously described ([@B5]; [@B46]).

Cell Treatment
--------------

SCs were cultured from the sciatic nerves of 1-day-old SD rats as previously described ([@B26]; [@B45]). In brief, to remove fibroblasts, anti-Thy1.1 antibody (Sigma, St. Louis, MO, United States) and rabbit complement (Invitrogen, Carlsbad, CA, United States) were further added to SCs isolated. Then SCs was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum in a humidified atmosphere of 5% CO~2~ and 95% air at 37°C ([@B23]). Primary cultured SCs were identified by immunostaining and flow cytometric analysis ([@B8]; [@B36]). H~2~O~2~ was used to establish the apoptosis model as previously reported ([@B24]). H~2~O~2~ was freshly diluted from 30% H~2~O~2~ stock solution with DMEM medium to a 400 μM final concentration prior to each experiment. To determine the effect of ABPPk on H~2~O~2~-exposed SCs, SCs were pretreated with ABPPk for 12 h followed by co-treatment of ABPPk with H~2~O~2~ for 24 h. In a single experiment, each treatment was performed in triplicate.

Cell Viability Assay
--------------------

Cell viability was determined by using MTT assay. SCs onto 96-well plates were treated differently with a density of 2 × 10^5^cells/ml. Then 20% sodium dodecyl sulfide (SDS) was added to dissolve the resulting formazan, following the incubation of SCs with MTT (0.5mg/ml) for 4 h at 37°C, which was described by measuring the absorbance (OD) values at 570 nm using Microplate reader (BioTek, United States) ([@B37]).

Tunel Staining of Apoptosis Cells
---------------------------------

The SCs were seeded at a density of 2 × 10^5^cells/ml to experience different treatments. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay by the DeadEndTM Fluorometric Tunel system (Promega, Madison, WI, United States) was showed according to manufacturer's instructions to detect the apoptotic cells. Differential interference contrast microscopy images were then obtained randomly ([@B30]). The ratio of Hoechst positive cells and Tunel positive cells were respectively calculated and at least five images of each sample in different visions were observed ([@B12]).

Flow Cytometry
--------------

The purity of primary cultured SCs was further evaluated by flow cytometric analysis with S100 antibody ([@B16]; [@B36]). And the extent of apoptosis was measured through AnnexinV-FITC apoptosis detection kit (BD Bioscience, San Jose, CA, United States) on the basis of the manufacturer's instruction. In brief, the SCs were resuspended in 1× Binding Buffer and stained with FITC-Annexin V and propidium iodide (PI) for 15 min at room temperature followed by washing twice with cold PBS. The apoptotic cells were analyzed by flow cytometry (BD Biosciences) ([@B50]). The relative ratio of early apoptotic cells was calculated which was repeated more than three times.

LDH Release Assay
-----------------

As an indicator of cell injury, LDH was released into the cell culture supernatant when cells undergo apoptosis ([@B6]). The cell viability was estimated by the amount of LDH release using LDH Detection Kit according to the manufacturer's protocol ([@B22]). The absorbance of samples was surveyed at 450 nm under a microplate reader (BioTek, United States).

Measurements of Intracellular SOD, MDA, and GSH Contents
--------------------------------------------------------

SCs cells were seeded in 6-well plates and grown overnight. Next, being exposed to H~2~O~2~ and ABPPk, the cellular SOD, MDA, and GSH were assessed by following the manufacturer's instructions of assay kits as described previously ([@B22]). The activity of SOD was detected at 550 nm with an ELx-800 microplate reader. The MDA contents in each cultured SCs were measured at a wavelength of 532 nm. The absorbance of GSH was measured at 405 nm by using a microplate reader (BioTek, United States).

Immunofluorescence Staining
---------------------------

The SCs were seeded in 24-well dishes. After treatment and fixation, the cells were incubated with anti-cleaved caspase-3 (1:1000; Abcam) or anti-S100 (1:1000; Abcam) primary antibody solution at 4°C overnight, and then, secondary antibodies (Donkey anti-Mouse IgG-Alex-488, 1:200; Goat anti-Rabbit IgG-Cy3, 1:200; Invitrogen) were added for 1 h at room temperature. Finally, the nuclei were stained with DAPI or Hoechst 33342. The reaction was observed and photographed under a fluorescence microscopy (AxioImager M2, Zeiss).

Western Blotting Analysis
-------------------------

The protein concentration was determined using the Micro BCA Protein Assay Kit (Pierce, Rockford, IL, United States) ([@B44]). Equal amounts of protein samples were separated on 10% SDS-PAGE and transferred to polyvinylidene fluoride membranes (Millipore, Bedford, MA, United States) ([@B14]). The membranes were blocked in 5% nonfat dry milk for 2 h and incubated with primary antibody anti-Bcl-2 (1:1000; Abcam), anti-Bax (1:1000; Abcam), anti-caspase-3 (1:1000; Abcam), anti-cleaved caspase-3 (1:1000; Abcam), anti-phospho ERK1/2 (1:1000; Abcam), anti-ERK1/2 (1:1000; Abcam), anti-PI3K (1:1000; Abcam), anti-phospho PI3K (1:1000; Abcam), anti-phospho AKT (1:1000; Abcam), anti-AKT (1:1000;Abcam), and anti-GAPDH (1:5000; Abcam) overnight at 4°C. After three washes with Tris-buffered saline with 0.1% Tween-20 (TBST), HRP-conjugated secondary antibodies (Pierce) were used to incubate the membranes for 1 h at room temperature. The membranes were developed using a chemiluminescence reagent (Roche) after three times washed in TBST and exposed to Kodak exposure films. GAPDH served as an internal control in order to make normalization and relative quantitative analysis of target protein expression ([@B9]).

Statistical Analysis
--------------------

All data are presented as mean ± SEM. All experiments were undertaken in triplicates. Statistical significance was conducted by one-way analysis of variance (ANOVA) with Bonferroni's *post hoc* test. A value of *P* \< 0.05 was considered to be statistically significant.

Results
=======

ABPPk Protected SCs Against H~2~O~2~-Induced Cell Cytotoxicity
--------------------------------------------------------------

The purity of primary cultured SCs was confirmed by immunocytochemistry with anti-S100 antibody (Figure [1A](#F1){ref-type="fig"}) and flow cytometry data (Figure [1B](#F1){ref-type="fig"}), which indicated that 97.32% of the cell population was S100-positive. The MTT results showed that H~2~O~2~ stimulation (100, 200, and 400 μM) could gradually reduce cell activity in a time- and dose-dependent manner. As shown in Figure [1C](#F1){ref-type="fig"}, an obvious decrease of viability was observed at 24 h with 400 μM H~2~O~2~ exposure (53.1 ± 4.9%, compared to the control). To evaluate the potential cytoprotective effect of ABPPk against oxidative stress-induced SCs death, SCs were pretreated with ABPPk at various concentrations (0.1, 0.25, and 0.5 μg/ml) for 12 h followed by exposure to H~2~O~2~ at a final concentration of 400 μM for 24 h. After pretreatment with ABPPk, the cell viability was significantly increased in a dose-dependent manner compared with H~2~O~2~ treatment alone. Specifically, treatment with ABPPk prior to H~2~O~2~ exposure at different concentrations (0.1, 0.25, and 0.5 μg/ml) increased the survival to 60.3 ± 2.2, 66.8 ± 3.2, and 87.3 ± 1.1%, respectively (*P* \< 0.01) (Figure [1D](#F1){ref-type="fig"}). These data suggest that ABPPk protected SCs against oxidative stress in SCs. In addition, ABPPk at these concentrations was not significantly cytotoxic.

![Effect of ABPPk on viability in H~2~O~2~-treated SCs. **(A)** Characterization of primary cultured SCs with S100 (green) immunocytochemistry combined with Hoechst 33342 staining (blue). **(B)** Representative flow cytometric analysis data illustrate 97.32% of S100-positive cells (M2). **(C)** SCs were induced by 100, 200, and 400 μM H~2~O~2~ for the indicated times (3, 6, 12, and 24 h). **(D)** SCs were pre-incubated with ABPPk (0.1, 0.25, and 0.5 μg/ml) for 12 h and then exposed to 400 μM H~2~O~2~. ^∗^*P* \< 0.05 vs. the control cells. ^\#^*P* \< 0.05 vs. the cells treated with H~2~O~2~ alone. Scale bar = 20 μm.](fnins-12-00868-g001){#F1}

ABPPk Protected SCs Against H~2~O~2~-Induced Cell Apoptosis
-----------------------------------------------------------

TUNEL analysis indicated that ABPPk prevented cultured SCs from H~2~O~2~-induced apoptosis. The TUNEL-positive cells were significantly increased from 3.04 ± 1.02 (control) to 21.86 ± 1.86% by exposure to H~2~O~2~ alone (*P* \< 0.01). After pretreatment with ABPPk (0.5 μg/ml) for 12 h, H~2~O~2~ stimulation was added and the number of TUNEL-positive cells significantly reduced to 10.58 ± 4.49% as compared to H~2~O~2~ stimulation alone (*P* \< 0.01) (Figures [2A,B](#F2){ref-type="fig"}). The apoptotic rate was also quantitatively analyzed by flow cytometry with AnnexinV-FITC/PI staining and provided further evidence that ABPPk pretreatment prevented cultured SCs from H~2~O~2~-induced apoptosis. The results of the apoptotic cell rate showed that ABPPk inhibited the early SCs apoptotic rate induced by H~2~O~2~ (Figures [2C,D](#F2){ref-type="fig"}). The ability of ABPPk to inhibit the SCs apoptosis under H~2~O~2~ conditions was exhibited according to the above results.

![Effects of ABPPk on H~2~O~2~-induced cell apoptosis. SCs were pretreated with ABPPk for 12 h and then exposed to H~2~O~2~ for additional 24 h. **(A)** Tunel-positive cells (red) indicate apoptotic cells and Hoechst 33342 (blue) was used to stain the nuclei. **(C)** The PI/AnnexinV-FITC staining and flow cytometry results show the ratio of cell apoptosis, the lower right panel which describes the early apoptotic cells. The percentage of TUNEL-positive cells and the rate of early apoptosis are shown by two histograms **(B,D)**, respectively. The results are expressed as the mean ± SEM, *n* = 5. ^∗^*P* \< 0.05 vs. the control cells. ^\#^*P* \< 0.05 vs. the cells treated with H~2~O~2~ alone. Scale bar = 50 μm.](fnins-12-00868-g002){#F2}

ABPPk Inhibits Apoptosis as Measured by Bax, Bcl-2, and Cleaved Caspase-3 in SCs
--------------------------------------------------------------------------------

To confirm ABPPk protection against H~2~O~2~-induced apoptosis, apoptosis-associated protein (Bcl-2, Bax, and cleaved caspase-3) levels were measured. Western blot analyses indicated that treatment with ABPPk significantly increased the expression of Bcl-2 and significantly decreased the expression of Bax and cleaved caspase-3, compared with that of H~2~O~2~ treatment alone (Figures [3A](#F3){ref-type="fig"}--[C](#F3){ref-type="fig"}). Immunofluorescence staining was performed to detect the activation of caspase-3, and cleaved caspase-3 induced by H~2~O~2~, while fewer ABPPk-treated cells displayed activated caspase-3 (Figure [3D](#F3){ref-type="fig"}).

![ABPPk inhibits apoptosis as measured by Bax, Bcl-2, and cleaved caspase-3 in SCs. The SCs were pretreated with 0.5 μg/ml of ABPPk and then exposed to 400 μM H~2~O~2~ to induce cell apoptosis. **(A)** The protein levels of Bax, Bcl-2, and cleaved caspase-3 were measured by Western blot with the antibodies is shown. GAPDH was used as a loading control. **(B,C)** Histograms show Western blot analysis data and cleaved caspase-3 expression data, respectively. **(D)** Caspase activation in H~2~O~2~-treated SCs assessed by cleaved caspase-3 immunocytochemistry. As shown in the images, the absence and presence of ABPPk was marked with S100 (green), DAPI (blue), and cleaved caspase-3 (red) staining. The results are expressed as the mean ± SEM, *n* = 5. ^∗^*P* \< 0.05 vs. the control cells. ^\#^*P* \< 0.05 vs. the cells treated with H~2~O~2~ alone. Scale bar = 50 μm (low magnification) and 20 μm (high magnification).](fnins-12-00868-g003){#F3}

ABPPk Attenuates H~2~O~2~-Induced Oxidative Injury
--------------------------------------------------

More and more evidence has shown that H~2~O~2~-induced oxidative stress and apoptosis plays the crucial role in SCs dysfunction and death. SOD and GSH levels were decreased due to the treatment of the cells by adding H~2~O~2~ along for 24 h (*P* \< 0.01, compared to the control group). However, co-incubation with ABPPk remarkably attenuated the changes in the content of SOD and GSH (*P* \< 0.01) (Figures [4A,B](#F4){ref-type="fig"}) when compared to H~2~O~2~-treated cells. Additionally, treating with H~2~O~2~ for 24 h, the intracellular MDA and LDH release were increased (*P* \< 0.01, compared to the control group), however, incubation with ABPPk produced a significant decrease in the intracellular level of MDA and LDH compared with the H~2~O~2~ group (*P* \< 0.01) (Figures [4C,D](#F4){ref-type="fig"}).

![The effects of ABPPk on the intracellular SOD, MDA, and GSH levels and LDH released by H~2~O~2~-injured SCs. **(A)** The SOD level of SCs H~2~O~2~ treated with the addition of ABPPk or not. **(B)** The intracellular GSH level of SCs treated with H~2~O~2~ in the absence or presence of ABPPk. **(C)** The intracellular MDA level of SCs treated with H~2~O~2~ in the absence or presence of ABPPk. **(D)** The release of LDH from SCs damaged by H~2~O~2~ with or without protection of ABPPk. The results are expressed as the mean ± SEM, *n* = 6. ^∗^*P* \< 0.05 vs. the control cells. ^\#^*P* \< 0.05 vs. the cells treated with H~2~O~2~ alone.](fnins-12-00868-g004){#F4}

PI3K/AKT and ERK1/2 Pathways Are Involved in ABPPk Treatment Suppressing H~2~O~2~ Induced Apoptosis in SCs
----------------------------------------------------------------------------------------------------------

Here, the expression levels of p-PI3K, PI3K, p-AKT, AKT, p-ERK1/2, and ERK1/2 were analyzed by Western blot. Compared with the control group, the p-PI3K/PI3K, p-AKT/AKT, and p-ERK1/2/ERK2 ratios were significantly reduced in the H~2~O~2~ group at 24 h. ABPPk treatment significantly reversed the decreased expression levels of p-PI3K/PI3K, p-AKT, and p-ERK1/2 in SCs exposed to H~2~O~2~ for 24 h (Figures [5A,B](#F5){ref-type="fig"}). These data suggest that ABPPk might suppress H~2~O~2~-induced apoptosis through the PI3K/AKT and ERK1/2 signaling pathways.

![ABPPk treatment activates the PI3K/AKT and ERK1/2 pathways in SCs. **(A)** SCs were treated with 400 μM H~2~O~2~ with or without 0.5 μg/ml ABPPk. The cells were collected and analyzed by Western blot for the expression of p-PI3K and PI3K, p-AKT and AKT, and p-ERK1/2 and ERK1/2. **(B)** Histogram shows data of p-PI3K/PI3K, p-AKT/AKT, and p-ERK/ERK levels from Western blot analyses. GAPDH was used as the protein loading control and band density normalization. ABPPk vs. control: ^&^*P* \< 0.05; H~2~O~2~ vs. control: ^∗^*P* \< 0.05; ABPPk + H~2~O~2~ vs H~2~O~2~: ^\#^*P* \< 0.05, *n* = 3.](fnins-12-00868-g005){#F5}

To further confirm our presumption that the role of ABPPk in the inhibition of H~2~O~2~-induced oxidative stress was related to the activation of PI3K/AKT and ERK1/2 pathways, two signal inhibitors, LY294002 and PD98059 (10 μM), respectively, were added to SCs. We found that the increased levels of p-PI3K, p-AKT, and p-ERK1/2 by ABPPk treatment were decreased after inhibitor treatment (Figures [6A,B](#F6){ref-type="fig"}). The agonists of these two signaling pathways had been performed (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}).

![Effects of the LY294002 and PD98059, PI3K inhibitor, and ERK1/2 inhibitor, on oxidative damage attenuated by ABPPk in SCs. **(A)** Western blot shows the p-PI3K/PI3K, p-AKT/AKT, and p-ERK/ERK in SCs pretreated with LY294002 (10 μM) and PD98059 (10 μM) for 30 min before the treatment of H~2~O~2~ (400 μM) and ABPPk (0.5 μg/ml) for 24 h. **(B)** Densitometric analyses illustrates the results of p-PI3K/PI3K, p-AKT/AKT, and p-ERK/ERK. H~2~O~2~ vs control: ^∗^*P* \< 0.05; ABPPk + H~2~O~2~ vs H~2~O~2~: ^\#^*P* \< 0.05; ABPPk + H~2~O~2~ + LY294002 or ABPPk + H~2~O~2~ + PD98059 vs ABPPk + H~2~O~2~: ^&^*P* \< 0.05, *n* = 3.](fnins-12-00868-g006){#F6}

In terms of the caspase-dependent pattern in our cell model and ABPPk was proved to reduce the caspase-3 activation (Figure [3](#F3){ref-type="fig"}), we further evaluate if LY294002 and PD98059 could affect the protection of ABPPk according to the change in the protein level of cleaved caspase-3. As described in Western blot, ABPPk treatment significantly prevented the H~2~O~2~ induced upregulation of cleaved caspase-3 in SCs, which was eliminated after the addition of the inhibitor LY294002 or PD98059 (Figures [7A,B](#F7){ref-type="fig"}). It was suggested that ABPPk plays a protective role on the cell apoptosis induced by H~2~O~2~ *via* the PI3K/AKT and ERK1/2 signaling pathways on the basis of the results.

![The protective ABPPk on apoptosis induced by H~2~O~2~ are partly impaired through the inhibition of the PI3K/AKT and ERK1/2 pathways. **(A)** Protein expression levels of cleaved caspase-3. **(B)** Quantification data of apoptotic markers cleaved caspase-3 in each group. H~2~O~2~ vs control: ^∗^*P* \< 0.05; ABPPk + H~2~O~2~ vs H~2~O~2~: ^\#^*P* \< 0.05; ABPPk + H~2~O~2~ + LY294002 or ABPPk + H~2~O~2~ + PD98059 vs ABPPk + H~2~O~2~: ^&^*P* \< 0.05, *n* = 3.](fnins-12-00868-g007){#F7}

Discussion
==========

In this study, H~2~O~2~ was used to establish an oxidative damage model of SCs. The experimental results demonstrated that ABPPk markedly protects SCs against H~2~O~2~-induced apoptosis, which may be due to the activation of PI3K/AKT and ERK1/2 signaling pathways. In addition, ABPPk could increase SOD and GSH activity and decrease MDA and LDH level in oxidation damaged SCs. Furthermore, ABPPk inhibited the apoptosis of SCs by increasing the level of Bcl-2 and decreasing the levels of Bax and cleaved caspase-3. In accordance with the results, ABPPk has a potent protective effect on peripheral nerve injuries by protecting SCs from oxidative stress-induced apoptosis.

*Achyranthes bidentata* was extensively investigated based on its multiple physiological functions, including anti-inflammatory, antirheumatic, antipyretic, and diuretic effects. A large amount of previous studies have discussed the effectiveness of ABPP in nervous system ([@B35], [@B34]). Recently, we separated the ABPP by HPLC and then one fraction was obtained, which was named ABPPk. It exhibits excellent neuron-protective efficiency ([@B5]; [@B46]). In this research, we have found that ABPPk could protect SCs from oxidative stress-induced damage. It is the first time that the protective roles of ABPPk on SCs in oxidative stress were investigated.

Such neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and the like attribute to oxidative stress that induces cell apoptosis are characterized by overloading ROS ([@B33]; [@B28]; [@B21]). Oxidative injuries to SCs bring about demyelination and slow formation of axon, which might play the important role in PNS injury and regeneration. H~2~O~2~ is widely used as an oxidant for studies *in vitro*. Previous research showed that H~2~O~2~ injury was able to induce cell apoptosis with concentration and time dependence ([@B42]; [@B20]; [@B1]). In the present experiment, it is confirmed that SCs treated with 400 μM H~2~O~2~ exhibits loss of cell viability. Pretreatment with 0.1--0.5 μg/ml ABPPk, however, significantly attenuate the loss of cell viability induced by H~2~O~2~ in a dose-dependent manner.

The apoptosis process could be regulated by proteins of Bcl-2 family through balancing of pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) products ([@B3]; [@B19]). In view of the results, ABPPk decreased H~2~O~2~-induced apoptosis of SCs by upregulation of Bcl-2 as well as downregulation of Bax. In addition, caspase 3 acts as an executor in the protease cascade reactions of cell apoptosis ([@B27]; [@B17]). The recent work suggested that caspase-3 is important for cell morphology and biochemical events related to the process of apoptosis ([@B25]; [@B48]). In our study, we confirmed that the cultured SCs showed a remarkable increase of cleaved caspase-3 after exposed to H~2~O~2~ and pretreatment with ABPPk significantly attenuated activation of caspase-3, which suggest that the potential anti-apoptotic effects of ABPPk against H~2~O~2~-induced cell apoptosis of SCs which might be regulated by the apoptosis-related caspase-3 protein expression and activation.

During the process of cell apoptosis, the MDA, as a byproduct induced by excessive ROS, is considered to be an indicator for oxidative stress ([@B41]). SOD and GSH, as antioxidants for the prevention of free-radical damage caused by ROS, provide a repair mechanism for oxidative stress ([@B41]). In our study, SOD and GSH were decreased after exposure to H~2~O~2~, indicating the impairment of SCs in oxidative stress. Moreover, the MDA level has an obvious elevation associated with an increase of LDH release. Nonetheless, these H~2~O~2~-induced cellular events were considerably blocked when SCs were co-cultured with ABPPk. The results reveal that the increase of endogenous antioxidant preservation may represent a potential mechanism of ABPPk for attenuating intracellular oxidative stress.

PI3K/AKT and ERK1/2 signaling, as we know, is vital to cell survival and cell apoptosis under stress exposure ([@B13]; [@B4]). In this research, the expression levels of p-PI3K, p-AKT, and p-ERK1/2 were reduced under the exposure to H~2~O~2~ and this situation was partially reversed by the ABPPk treatment. It shows that ABPPk activate the PI3K/AKT and ERK1/2 pathways in SCs resulting in the suppression of effect of H~2~O~2~ stress induced-apoptosis of SCs. In accordance with the results, the effects of pharmacological inhibitors for PI3K/AKT (LY294002) and ERK1/2 (PD98059) in SCs, and the reduction of cell death by ABPPk depressed by inhibitor treatment were demonstrated.

In summary, our study indicates that ABPPk could protect SCs from H~2~O~2~-induced oxidative stress and cell apoptosis, as well as activation of PI3K/AKT and ERK1/2 signaling pathways. The results lay a ground work for deeper understanding of the molecular mechanism of ABPPk-regulated anti-apoptotic activity in SCs and also provide valuable information of new strategies for better clinical treatments of peripheral nerve injuries.
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Effects of the PI3K/AKT agonists 1,3-Dicaffeoylquinic acid and ERK1/2 agonists Honokiol on ABPPk induced attenuation of oxidative damage. **(A)** SCs were treated with the agonists 1,3-Dicaffeoylquinic acid (10 μM) and Honokiol (10 μM) for 1 h before the treatment of H~2~O~2~ (400 μM) and ABPPk (0.5 μg/ml) for 24 h. **(B)** Densitometric analyses illustrates the results of p-AKT/AKT and p-ERK/ERK. H~2~O~2~ vs control: ^∗^*P* \< 0.05; ABPPk + H~2~O~2~ vs H~2~O~2~: ^\#^*P* \< 0.05; ABPPk + H~2~O~2~ + 1,3-Dicaffeoylquinic acid or ABPPk + H~2~O~2~ + Honokiol vs. ABPPk + H~2~O~2~: ^&^*P* \< 0.05, *n* = 3.

###### 

Click here for additional data file.
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